Fei Xu

机构：Jiangnan University, Beijing Chao-Yang Hospital, Capital Medical University · ORCID：0000-0002-9485-4298

发表论文 37 篇 · 总被引 1014 次 · h-index 16

代表论文

• FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2 (2021 · Molecular Cancer · 被引 140)
• The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B (2020 · Molecular Therapy — Nucleic Acids · 被引 95)
• BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair (2021 · Oncogene · 被引 85)
• Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma (2021 · Clinical and Translational Medicine · 被引 76)
• CircRNA: Functions, Applications and Prospects (2024 · Biomolecules · 被引 42)
• Circ0004390 promotes cell proliferation through sponging miR-198 in ovarian cancer (2020 · Biochemical and Biophysical Research Communications · 被引 34)